Background And Purpose: Kelchlike protein 11 antibodies (KLHL11-IgGs) were first described in 2019 as a marker of paraneoplastic neurological syndromes (PNSs). They have mostly been associated with testicular germ cell tumors (tGCTs).
Methods: Two patients with KLHL11-IgG encephalitis are reported, and the literature is comprehensively reviewed.